|
KDM4D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.12519999562988E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.06720000193317E-08 |
| Normal-vs-Stage2 |
1.419760E-03 |
| Normal-vs-Stage3 |
8.63589999955394E-07 |
| Normal-vs-Stage4 |
7.72069963517197E-10 |
| Stage1-vs-Stage2 |
5.778000E-02 |
| Stage1-vs-Stage3 |
5.886000E-01 |
| Stage1-vs-Stage4 |
1.528340E-02 |
| Stage2-vs-Stage3 |
1.732620E-01 |
| Stage2-vs-Stage4 |
2.395900E-03 |
| Stage3-vs-Stage4 |
1.790010E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.2745000023744E-08 |
| Normal-vs-AfricanAmerican |
2.183800E-03 |
| Normal-vs-Asian |
4.25820000038435E-07 |
| Caucasian-vs-AfricanAmerican |
4.808200E-01 |
| Caucasian-vs-Asian |
8.893000E-01 |
| AfricanAmerican-vs-Asian |
5.114800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.14520000038532E-07 |
| Normal-vs-Female |
1.50930000053506E-07 |
| Male-vs-Female |
5.364800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.88079999855029E-08 |
| Normal-vs-Age(41-60Yrs) |
3.96020000015262E-07 |
| Normal-vs-Age(61-80Yrs) |
2.09039999998772E-06 |
| Normal-vs-Age(81-100Yrs) |
9.075300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.817410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.097590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.262800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.639000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.875000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.110400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.305800E-01 |
| Classical-VS-Follicular |
7.620300E-02 |
| Classical-VS-Other |
2.320200E-01 |
| Classical-VS-Normal |
1.27710000019654E-07 |
| Tall-VS-Follicular |
1.408800E-01 |
| Tall-VS-Other |
3.277800E-01 |
| Tall-VS-Normal |
1.3617999999882E-06 |
| Follicular-VS-Other |
1.260960E-01 |
| Follicular-VS-Normal |
2.16169999999183E-05 |
| Other-VS-Normal |
3.780500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.84630000363984E-08 |
| Normal-vs-N1 |
1.05380038029068E-10 |
| N0-vs-N1 |
1.92452999999704E-05 |
|
|
